共 69 条
[1]
Allenbach Y(2020)Immune-mediated necrotizing myopathy: clinical features and pathogenesis Nat Rev Rheumatol 16 689-701
[2]
Benveniste O(2018)Classification and management of adult inflammatory myopathies Lancet Neurol 17 816-828
[3]
Stenzel W(2018)Autoantibodies in myositis Nat Rev Rheumatol 14 290-302
[4]
Boyer O(2018)Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies JAMA Neurol 75 1528-1537
[5]
Selva-O'Callaghan A(2018)224th ENMC International Workshop: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14–16 October 2016 Neuromuscul Disord 28 87-99
[6]
Pinal-Fernandez I(2012)Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome Arch Neurol 69 728-732
[7]
Trallero-Araguás E(2017)Longitudinal course of disease in a large cohort of myositis patients with autoantibodies recognizing the signal recognition particle Arthritis Care Res (Hoboken) 69 263-270
[8]
Milisenda JC(2019)In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy Ann Rheum Dis 78 131-139
[9]
Grau-Junyent JM(2002)Epitope spreading in immune-mediated diseases: implications for immunotherapy Nat Rev Immunol 2 85-95
[10]
Mammen AL(2021)Idiopathic inflammatory myopathies Nat Rev Dis Primers 7 86-994